What is the Return on Assets (ROA) of ASKA Pharmaceutical Holdings Co this year?
The Return on Assets (ROA) of ASKA Pharmaceutical Holdings Co is 0.08 undefined this year.
In 2024, ASKA Pharmaceutical Holdings Co's return on assets (ROA) was 0.08, a 61.44% increase from the 0.05 ROA in the previous year.
ASKA Pharmaceutical Holdings Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Comparing ASKA Pharmaceutical Holdings Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Investors consider ASKA Pharmaceutical Holdings Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Variations in ASKA Pharmaceutical Holdings Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
The Return on Assets (ROA) of ASKA Pharmaceutical Holdings Co is 0.08 undefined this year.
The ROA of ASKA Pharmaceutical Holdings Co has increased by 61.44% compared to the previous year.
A high ROA is advantageous for investors of ASKA Pharmaceutical Holdings Co, as it indicates that the company efficiently utilizes its assets and generates good profits.
A low ROA can be unfavorable for investors of ASKA Pharmaceutical Holdings Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
An increase in ROA of ASKA Pharmaceutical Holdings Co can be an indicator of improved efficiency in asset utilization and higher profitability.
A reduction in the ROA of ASKA Pharmaceutical Holdings Co can be an indicator of lower asset efficiency and profitability.
Some factors that can influence the ROA of ASKA Pharmaceutical Holdings Co include revenue, operating costs, asset structure, and industry average.
The ROA of ASKA Pharmaceutical Holdings Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
To improve ROA, ASKA Pharmaceutical Holdings Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
Over the past 12 months, ASKA Pharmaceutical Holdings Co paid a dividend of 45 JPY . This corresponds to a dividend yield of about 2.03 %. For the coming 12 months, ASKA Pharmaceutical Holdings Co is expected to pay a dividend of 48.19 JPY.
The current dividend yield of ASKA Pharmaceutical Holdings Co is 2.03 %.
ASKA Pharmaceutical Holdings Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
ASKA Pharmaceutical Holdings Co paid dividends every year for the past 12 years.
For the upcoming 12 months, dividends amounting to 48.19 JPY are expected. This corresponds to a dividend yield of 2.17 %.
ASKA Pharmaceutical Holdings Co is assigned to the 'Health' sector.
To receive the latest dividend of ASKA Pharmaceutical Holdings Co from 12/1/2024 amounting to 25 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
The last dividend was paid out on 12/1/2024.
In the year 2023, ASKA Pharmaceutical Holdings Co distributed 28 JPY as dividends.
The dividends of ASKA Pharmaceutical Holdings Co are distributed in JPY.
Our stock analysis for ASKA Pharmaceutical Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ASKA Pharmaceutical Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.